Eaton Vance Management Abbott Laboratories Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Abbott Laboratories stock. As of the latest transaction made, Eaton Vance Management holds 4,074,583 shares of ABT stock, worth $458 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

4,074,583

Previous 4,050,783 0.59%

Holding current value

$458 Million

Previous $440 Million 10.42%

% of portfolio

0.58%

Previous 0.62%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $2.3 Million - $2.67 Million	23,800 Added 0.59%	4,074,583 $394 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $4.31 Million - $5.2 Million	-42,178 Reduced 1.03%	4,050,783 $440 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $34.5 Million - $42.1 Million	302,449 Added 7.98%	4,092,961 $484 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $33.6 Million - $41.2 Million	291,107 Added 8.32%	3,790,512 $527 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $4.16 Million - $4.6 Million	-35,644 Reduced 1.01%	3,499,405 $408 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $91.5 Million - $108 Million	-865,371 Reduced 19.67%	3,535,049 $410 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $61.8 Million - $72.8 Million	-567,969 Reduced 11.43%	4,400,420 $527 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $12.4 Million - $13.5 Million	-118,245 Reduced 2.32%	4,968,389 $544 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $9.23 Million - $11.2 Million	-100,720 Reduced 1.94%	5,086,634 $554 Million
Q2 2020 Nov 20, 2020	SELL	$76.57 - $98.0 $301,992 - $386,512	-3,944 Reduced 0.08%	5,187,354 $474 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $3.23 Million - $4.13 Million	-42,171 Reduced 0.81%	5,191,298 $474 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $4.96 Million - $7.26 Million	78,987 Added 1.53%	5,233,469 $414 Million
Q4 2019 Feb 11, 2020	SELL	$78.51 - $87.4 $5.39 Million - $6 Million	-68,619 Reduced 1.31%	5,154,482 $448 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $7.11 Million - $7.71 Million	-86,869 Reduced 1.64%	5,223,101 $437 Million
Q2 2019 Nov 21, 2019	BUY	$72.88 - $85.0 $1.78 Million - $2.07 Million	24,380 Added 0.46%	5,309,970 $447 Million
Q2 2019 Aug 16, 2019	SELL	$72.88 - $85.0 $12.1 Million - $14.1 Million	-166,404 Reduced 3.05%	5,285,590 $444 Million
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $15.9 Million - $19.2 Million	240,393 Added 4.61%	5,451,994 $436 Million
Q4 2018 Feb 07, 2019	BUY	$65.56 - $74.27 $64.6 Million - $73.2 Million	984,962 Added 23.3%	5,211,601 $377 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $4.52 Million - $5.46 Million	74,391 Added 1.79%	4,226,639 $310 Million
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $28.5 Million - $31.5 Million	495,687 Added 13.56%	4,152,248 $253 Million
Q1 2018 May 07, 2018	BUY	$56.27 - $63.62 $51.4 Million - $58.1 Million	913,126 Added 33.28%	3,656,561 $219 Million
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $7.23 Million - $7.74 Million	134,710 Added 5.16%	2,743,435 $157 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $125 Million - $140 Million	2,608,725	2,608,725 $139 Million

Others Institutions Holding ABT

# of Institutions

3,189

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Abbott Laboratories Transaction History